lung cancer
-
OncoMed’s experimental lung cancer drug failed a mid-stage study
Apr 17, 2017News Hour: OncoMed Pharmaceuticals Inc said on Monday its experimental lung cancer drug failed a mid-stage study, sending its shares tumbling 30 percent in premarket trading. This is the second major setback for OncoMed this month... -
Roche’s Alecensa kept people with lung cancer alive longer than Pfizer’s Xalkori
Apr 10, 2017News Hour: Roche’s Alecensa kept people with a specific lung cancer alive longer without their disease progressing than Pfizer’s Xalkori, the Swiss drugmaker said on Monday, as it seeks to move in on the U.S. company’s... -
AstraZeneca won approval for lung cancer pill Tagrisso in China
Mar 27, 2017News Hour: AstraZeneca said on Monday it had won approval for its lung cancer pill Tagrisso in China, a key market for the potential blockbuster medicine. Tagrisso is designed to help cancer patients with certain genetic... -
Immunotherapy drug gives non-small-cell lung cancer patients extra four months of life with fewer side effects compared to chemotherapy
Dec 18, 2016News Hour: Patients with advanced non-small-cell lung cancer survive four months longer with fewer side effects on an immunotherapy drug called a tezolizumab compared to chemotherapy, according to a phase 3 clinical trial published in The... -
Powerful new campaign urges tobacco users to believe lung cancer warnings on tobacco packs
Nov 10, 2016News Hour: A powerful national mass media campaign to show the deadly harm of tobacco – and support the warning labels now on tobacco packs in Bangladesh – was launched today by Mr. Zahid Maleque MP,... -
Roche lung cancer drug success adds to pressure on Bristol
Oct 9, 2016News Hour: Lung cancer patients on Roche’s immune system-boosting drug Tecentriq lived on average 4.2 months longer than those taking chemotherapy in a pivotal study, pressuring Bristol-Myers Squibb’s dominant position in the field. The trial involved... -
Whole brain radiotherapy offers little benefit to people whose lung cancer has spread to the brain
Sep 5, 2016News Hour: People with the most common type of lung cancer whose disease has spread to the brain could be spared potentially harmful whole brain radiotherapy, according to new research published in The Lancet. The phase... -
30-day mortality following chemotherapy for breast and lung cancer in England
Aug 30, 2016News Hour: For the first time, national data on 30-day mortality for patients with breast and lung cancer treated with chemotherapy have been collected and analysed in order to help clinical teams review and improve patient...
